周三下午盘中,和黄医药(00013)股价出现大涨5.1%的行情,一直成为市场关注的焦点。
虽然没有直接相关的新闻报道可以解释股价上涨的原因,但行业数据显示,该股所属的药品行业当日整体上涨0.32%,表现相对良好。同时和黄医药基本面较为健康,最新财报显示盈利能力依然强劲,每股收益达0.23港元,股价估值仅31倍市盈率,在分析师看来估值具备吸引力。
另外,目前在分析师评级中,有100%的机构给予该股"买入"评级,且无任何卖出或持有评级,折射出机构投资者对和黄医药的增长前景持续看好。综合来看,包括行业表现利好、公司基本面依然强劲以及机构看好等因素,可能共同推动和黄医药当日股价出现估值修复,使其迎来一定程度的上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.